UL UNILEVER PLC IFRS
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 217410 · Reporting currency EUR · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-3.8%
TTM net income YoY64.9%
TTM EPS YoY67.4%
Revenue 3-yr CAGR-5.6%
Net income 3-yr CAGR7.4%
Margins
Gross margin46.9%
Operating margin17.9%
Net margin18.7%
FCF margin13.7%
EBITDA margin20.5%
Returns
ROE53.3%
ROA12.6%
ROIC (approx.)50.8%
Asset turnover0.67x
Leverage & solvency
Liabilities / assets75.0%
Debt / equity0.00x
Current ratio0.79x
Interest coverage8.83x
Cash quality & payout
Operating cash flow / net income0.88x
Accruals ratio1.5%
Payout ratio47.0%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: EUR | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 50.50B | 52.48B | 51.68B | 60.07B | 52.44B |
| Cost of revenue | 26.79B | 27.98B | 29.18B | 35.91B | 30.26B |
| Gross profit | 23.71B | 24.50B | 22.50B | 24.17B | 22.18B |
| R&D expense | 836.00M | 892.00M | 853.00M | 908.00M | 847.00M |
| SG&A expense | 13.62B | 14.30B | 13.42B | 14.48B | 12.55B |
| Operating income | 9.04B | 8.83B | 9.00B | 10.76B | 8.70B |
| Interest expense | 1.02B | 994.00M | 922.00M | 818.00M | 491.00M |
| Pretax income | 8.69B | 8.37B | 8.63B | 10.34B | 8.56B |
| Income tax | 2.48B | 2.33B | 1.99B | 2.07B | 1.94B |
| Net income | 9.47B | 5.74B | 6.49B | 7.64B | 6.05B |
| EBITDA | 10.35B | 10.07B | 10.14B | 12.48B | 10.45B |
| EPS (basic) | 4.33 | 2.59 | 2.90 | 3.00 | 2.33 |
| EPS (diluted) | 4.32 | 2.58 | 2.89 | 2.99 | 2.32 |
| Weighted avg. shares (diluted) | 2.20B | 2.23B | 2.25B | 2.56B | 2.61B |
| Balance sheet | |||||
| Cash & equivalents | 3.94B | 6.14B | 4.16B | 4.33B | 3.42B |
| Receivables | 7.35B | 6.01B | 5.78B | 7.06B | 5.42B |
| Inventory | 4.04B | 5.18B | 5.12B | 5.93B | 4.68B |
| Current assets | 17.07B | 19.19B | 17.90B | 19.16B | 17.40B |
| PP&E, netmay include right-of-use assets (IFRS) | 7.83B | 10.26B | 9.38B | 9.42B | 10.35B |
| Goodwill | 17.71B | 22.31B | 21.11B | 21.61B | 20.33B |
| Intangibles | 17.05B | 18.59B | 18.36B | 18.88B | 18.26B |
| Total assets | 70.47B | 79.75B | 75.27B | 77.82B | 75.09B |
| Current liabilities | 21.66B | 25.23B | 23.51B | 25.43B | 24.78B |
| Total liabilities | 52.88B | 57.20B | 54.50B | 56.12B | 55.35B |
| Shareholders' equity | 15.53B | 19.99B | 18.10B | 19.02B | 17.11B |
| Shares outstanding | — | 2.48B | 2.50B | 2.53B | — |
| Cash flow statement | |||||
| Operating cash flow | 8.35B | 9.52B | 9.43B | 7.28B | 7.97B |
| Capital expenditure | 1.42B | 1.38B | 1.19B | 1.46B | 1.11B |
| Free cash flow | 6.93B | 8.14B | 8.23B | 5.83B | 6.86B |
| Investing cash flow | -3.12B | -625.00M | -2.29B | 2.45B | -3.25B |
| Financing cash flow | -6.81B | -6.94B | -7.19B | -8.89B | -7.10B |
| Depreciation & amortization | 1.31B | 1.24B | 1.15B | 1.73B | 1.75B |
| Stock-based compensation | 255.00M | 292.00M | 192.00M | 177.00M | 161.00M |
| Dividends paid | 4.45B | 4.32B | 4.33B | 4.36B | 4.46B |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.